Event Type
Disclosure
Mandatory
Variant
8-K
Results of Operations and Financial Condition. On February 26, 2026 , Crinetics Pharmaceuticals, Inc. (the “Company” or “Crinetics”) issued a press release repo
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated February 26, 2026. 104 Cover Page Interactive Data File (embedd